MoneyWorks4Me

Themis Medicare - Quaterly Results

10 Aug 2023 Evaluate
The quarter ended June 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 966.48 millions.A humble growth in net profit of 7.92% reported in the quarter ended June 2023 to Rs. 125.55  millions from Rs. 116.34 millions.The company reported a good operating profit of 223.97 millions compared to 210.45 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 966.48 944.35 2.34 966.48 944.35 2.34 3543.23 3946.14 -10.21
Other Income 6.53 6.85 -4.67 6.53 6.85 -4.67 115.05 65.41 75.89
PBIDT 223.97 210.45 6.42 223.97 210.45 6.42 789.67 1021.92 -22.73
Interest 24.94 22.58 10.45 24.94 22.58 10.45 95.64 87.74 9.00
PBDT 199.03 187.87 5.94 199.03 187.87 5.94 694.03 934.18 -25.71
Depreciation 30.25 24.60 22.97 30.25 24.60 22.97 104.95 94.80 10.71
PBT 168.78 163.27 3.37 168.78 163.27 3.37 589.08 839.38 -29.82
TAX 43.23 46.93 -7.88 43.23 46.93 -7.88 156.14 223.81 -30.24
Deferred Tax 0.73 0.63 15.87 0.73 0.63 15.87 6.14 56.31 -89.10
PAT 125.55 116.34 7.92 125.55 116.34 7.92 432.94 615.57 -29.67
Equity 92.03 92.00 0.03 92.03 92.00 0.03 92.03 92.00 0.03
PBIDTM(%) 23.17 22.29 3.99 23.17 22.29 3.99 22.29 25.90 -13.94
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..